OLMA
Olema Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$14.71
-0.20 ▼ -1.34%
🌙 3월 13일 5:11 PM ET (한국 3/14 06:11)
$15.00
+0.29 ▲ +1.97%
| Index | RUT | P/E | - | EPS (ttm) | -1.81 | Insider Own | 21.4% | Shs Outstand | 0.07B | Perf Week | -31.74% |
| Market Cap | 1.16B | Forward P/E | - | EPS next Y | -17.08% | Insider Trans | -4.97% | Shs Float | 0.06B | Perf Month | -37.8% |
| Enterprise Value | 0.83B | PEG | - | EPS next Q | -0.51 | Inst Own | 98.31% | Short Float | 13.36% | Perf Quarter | -52.05% |
| Income | -0.15B | P/S | - | EPS this Y | 14.06% | Inst Trans | 24.55% | Short Ratio | 4.76 | Perf Half Y | 83.88% |
| Sales | 0.00B | P/B | 3.28 | EPS next 5Y | -3.11% | ROA | -51.48% | Short Interest | 8.26M | Perf YTD | -41.16% |
| Book/sh | 4.48 | P/C | 3.52 | EPS past 3/5Y | -7.01% -83% | ROE | -59.22% | 52W High | -59.43% ($36.26) | Perf Year | 236.61% |
| Cash/sh | 4.18 | P/FCF | - | Sales past 3/5Y | - | ROIC | -48.25% | 52W Low | 414.34% ($2.86) | Perf 3Y | 274.3% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 17.23% | Gross Margin | - | Volatility(W/M) | 15.24% 8.02% | Perf 5Y | -68.78% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 1.8 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 8.03 | EPS Q/Q | 18.4% | Profit Margin | - | RSI (14) | 19.9 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 8.03 | Sales Q/Q | - | SMA20 | -31.6% ($21.51) | Beta | 2.14 | Target Price | $43.73 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 11000000 | SMA50 | -39.19% ($24.19) | Rel Volume | 0.73 | Prev Close | $14.91 |
| Employees | 96 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | -3.24% - | SMA200 | 4.74% ($14.04) | Avg Volume(3M) | 1.73M | Price | $14.71 |
| IPO | 2020/11/19 | Option/Short | Yes/Yes | Trades | 13894 | Volume | 1,259,017 | Change | -1.34% |
뉴스 로딩 중...